MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    The Differences in the Perception of Parkinson’s Disease-related Motor Complications between Patients and Physicians

    T. Tezuka, R. Okochi, Y. Sakai, T. Nukariya, S. Okusa, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: This study aimed to evaluate the differences in the perception of Parkinson’s disease (PD)-related motor complications by utilizing questionnaires answered by both PD patients…
  • 2024 International Congress

    The Impact of Parkinson’s Disease on Causal Perception

    Z. Rostami, M. Vaziri Pashkam, M. Salari (Tehran, Islamic Republic of Iran)

    Objective: Investigating the visual causality perception in Parkinson's disease (PD) patients and comparing their performance with that of healthy individuals. Background: Parkinson’s disease (PD) is…
  • 2024 International Congress

    The Prevalence of Parkinson’s Disease with Dementia in a door to door survey done in a rural district in Hai, Kilimanjaro.

    E. Assey, R. Morton, J. Josephat, R. Valecha (Kilimanjaro, United Republic of Tanzania)

    Objective: To determine the prevalence of dementia in persons living with Parkinson's disease in a door to door survey. Background: Research suggests that up to…
  • 2024 International Congress

    Non-motor Symptoms and Quality-of-life of People with Parkinson’s disease

    K. Prakash, X. Xiao, EC. Lim (Singapore, Singapore)

    Objective: To assess the association between non-motor symptoms and quality of life of people with Parkinson's disease of different motor subtypes. Background: Little is known…
  • 2024 International Congress

    Perspective of people living with early Parkinson’s Disease: most common, burdensome, and worrisome symptoms

    S. Messner, T. Carmody, R. Park, B. Jones, A. Hursey, E. Lucassen (Basel, Switzerland)

    Objective: To assess the most common, burdensome and worrisome symptoms experienced by people living with early Parkinson’s Disease (ePD). Background: Research on symptom frequency and…
  • 2024 International Congress

    Evaluating the Impact of the Pain Self-Management Program in PD

    A. Zawar (Lynnwood, USA)

    Objective: The program aims to provide PD individuals with skill sets, knowledge, and tools necessary to effectively self-manage their pain through non-pharmacological approaches. By empowering…
  • 2024 International Congress

    Parkinson’s disease biomarkers in human olfactory cleft mucus

    J. Morley, N. Cohen, S. Koganti, S. Wood, H. Wang (Philadelphia, USA)

    Objective: To investigate and identify biomarkers for PD from human olfactory cleft mucus Background: Olfactory loss is an early symptom of PD, often preceding motor…
  • 2024 International Congress

    Deep learning-based Prediction of Visual Dysfunction in Parkinson’s Disease from 31 Brain Regions of Interest using Quantitative Diffusion MRI

    C. Raimondo, L. Singanamala, M. Alizadeh (Philadelphia, USA)

    Objective: Compare the performance of deep learning and machine learning models trained on quantitative diffusion measurements in the prediction of visual dysfunction in Parkinson’s Disease…
  • 2024 International Congress

    Dopamine Dysregulation in Parkinson’s Disease and Substance Use: Therapeutic Use and Compulsive Behaviors Thin Line

    J. Hall, R. Islam, D. Nolasco, B. Carr (GAINESVILLE, USA)

    Objective: Parkinson's Disease (PD) inherently disrupts dopaminergic transmission, primarily within the nigrostriatal pathway, necessitating dopaminergic therapies. However, these therapies can lead to Dopamine Dysregulation Syndrome…
  • 2024 International Congress

    Characteristics of Parkinson’s disease and associated healthcare resource utilization trends in a US all-payer health administrative claims database

    W. Zhang, S. Shuvo, A. Gabriel, A. Yaldo, G. Agreda, C. Goetzsche, T. Machewitz, M. Nadimi, J. Lott (Whippany, USA)

    Objective: To describe sociodemographic characteristics and healthcare resource utilization (HRU) among Parkinson’s disease (PD) patients across US health insurance plans. Background: PD affects nearly 1…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley